Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab–bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study
Authors 0
- Author list not loaded yet.
Cited by 6 stored of 132
6 results
References 3
3 results